ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,011.12
      -0.22%
      US Tech 100
      16,901.20
      -0.78%
      Dow Jones
      37,775.38
      0.06%
      Brent Oil
      86.415
      -0.66%
      Bitcoin
      63,474.26
      3.58%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX
      6. Antibe Therapeutics Inc (ATE)

      7. Antibe Therapeutics Inc (ATE) News

      ATE Antibe Therapeutics Inc

      0.295
      0.00 (0.00%)
      Apr 18 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Antibe Therapeutics Inc ATE Toronto Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 0.295 10:26:21
      Open Price Low Price High Price Close Price Prev Close
      0.295
      more quote information »

      Recent News

      Date Time Source Heading
      4/16/202417:00BWAntibe Announces TSX Delisting Review
      4/09/202419:00BWAntibe Announces Granting of Initial Order Under Companies'..
      4/09/202411:25PRNCACanadian Investment Regulatory Organization Trade Resumption..
      4/09/202409:44PRNCASuspension de la négociation par l'Organisme canadien de..
      4/09/202409:42PRNCACanadian Investment Regulatory Organization Trading Halt -..
      4/09/202407:00BWAntibe to File an Application for an Initial Order Under..
      4/01/202407:00BWAntibe Announces FDA Clinical Hold on Otenaproxesul and..
      3/20/202407:00BWAntibe to Present Otenaproxesul PK/PD Results at the ASRA..
      3/07/202407:00BWAntibe to Present Otenaproxesul PK/PD Results at the..
      3/04/202407:00BWAntibe Announces Unfavorable Decision in Arbitration With..
      2/14/202407:00BWAntibe Reports Q3 2024 Interim Financial and Operating..
      2/01/202407:00BWAntibe Extends Early Warrant Exercise Incentive Program
      12/29/202307:00BWAntibe Announces Early Warrant Exercise Incentive Program
      12/12/202307:00BWAntibe Therapeutics Announces Amendment to Warrant Terms
      11/13/202307:00BWAntibe Reports Q2 2024 Interim Financial and Operating..
      11/09/202307:00BWAntibe Reports PK Results of First Clinical Study of..
      11/01/202307:00BWAntibe Completes First Clinical Study of Otenaproxesul’s New..
      10/18/202307:00BWAntibe Initiates First Clinical Study of Otenaproxesul’s New..
      9/28/202307:00BWAntibe Receives Approval to Initiate PK/PD Study of..
      9/08/202317:00BWAntibe Announces Results of 2023 Annual Meeting
      8/21/202315:23PRNCAToronto Stock Exchange, Antibe Therapeutics Inc., View From..
      8/14/202307:00BWAntibe Reports Q1 2024 Interim Financial and Operating..
      6/29/202307:30BWAntibe Reports 2023 Year-End Results and Business Highlights
      4/25/202307:00BWAntibe’s Chief Medical Officer to Present at the 2023..

      Your Recent History

      TSX
      ATE
      Antibe Therapeutics
      Delayed Upgrade Clock